For example, poly (ADP-ribose) polymerase (PARP) inhibitors for BRCA1/2 mutation-positive cases in ovarian cancer and programmed cell death protein 1 (PD-1) monoclonal antibody for microsatellite instability (MSI-high) in solid tumors. Here, PDCD1 is linked to ovarian cancer.